Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Ad­vanced Therapy Medic­i­nal Prod­ucts (ATMP)

Advanced Therapy Medicinal Products (ATMPs) are medicinal products for the use in humans based on genes, tissues or cells.

Chimeric antigen receptor (CAR) on T-cell (Source: Juan Gaertner/ScienceFotoLibrary/Getty Images)

They provide innovative methods of treating diseases and injuries. In Germany, the Paul-Ehrlich-Institut (PEI) is the competent authority for this group of medicines.

ATMPs include gene therapeutics, somatic cell therapeutics, and tissue engineered products.

Updated: 21.11.2019